Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04644172 · ClinicalTrials.gov registry record · NA

Improving Thinking in Everyday Life After Covid-19

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT04644172 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04644172, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

The purpose of this initial study is to evaluate a new form of cognitive rehabilitation therapy for improving your ability to think, particularly how rapidly you process information that you receive from your senses, e.g., sight, hearing, and smell. The study will also test how often and how well you carry out tasks that rely on thinking in your daily life. You will be randomly assigned to receive the new therapy soon or about three months later. In other words, your treatment schedule will be determined by chance. The new therapy involves intensive, repetitive cognitive exercises (up to 3.5hr/day for 10 consecutive weekdays) with rest periods interspersed as needed.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Speed of Processing Training
  • BEHAVIORAL Transfer Package from CI Therapy
  • BEHAVIORAL Instrumental Activities of Daily Living Shaping

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-01-01
Est. Completion 2024-05-15
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04644172

The ClinicalTrials.gov registry entry for NCT04644172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.

NCT04644172 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04644172 about?

NCT04644172 is a clinical study titled "Improving Thinking in Everyday Life After Covid-19". The purpose of this initial study is to evaluate a new form of cognitive rehabilitation therapy for improving your ability to think, particularly how rapidly you process information that you receive from your senses, e.g., sight, hearing, and smell. The study will also test how often and how well yo...

What is the current status of trial NCT04644172?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-01-01. Estimated completion is 2024-05-15.

What interventions are being tested in trial NCT04644172?

The interventions under investigation include: Usual Care (OTHER), Speed of Processing Training (BEHAVIORAL), Transfer Package from CI Therapy (BEHAVIORAL), Instrumental Activities of Daily Living Shaping (BEHAVIORAL).

Who is sponsoring clinical trial NCT04644172?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.